FDA Inspection 1013962 — Flexion Therapeutics, Inc.

Flexion Therapeutics, Inc. — FEI 3010734762

The FDA completed an inspection of Flexion Therapeutics, Inc. on Jun 13, 2017 in Burlington, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 13, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Burlington, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.